多omics分析确定了CD83+巨细胞中的线粒体功能障碍是糖尿病外围神经病变进展的关键事件

Yumin Lin1, Yuanyuan Shen1, Jiahua Wu2

  • 1Department of Endocrinology and Metabolism, the First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu, China.

Neurobiology of disease
|January 8, 2026
PubMed
概括

糖尿病外围神经病变 (DPN) 的进展涉及线粒体功能障碍和CD83+巨细胞. TIMM23被确定为DPN进展的关键标志物,提供潜在的诊断和治疗策略.